论文部分内容阅读
目的:探讨复方福尔可定糖浆在小儿急性呼吸道感染止咳化痰的的临床疗效和安全性。方法:选取62例急性上下呼吸道感染并伴有咳嗽咳痰的患儿,将其随机分为研究组和对照组各31例。研究组给予复方福尔可定糖浆,对照组采用小儿肺热咳喘口服液。结果:治疗结束后,对照组和研究组的总有效率分别为61.29%、90.32%,两组总有效率比较,差异具有统计学意义(P<0.05);研究组治疗后的咳嗽、排痰困难以及住院天数均明显少于对照组,差异具有统计学意义(P<0.05)。结论:复方福尔可定糖浆治疗小儿急性呼吸道感染,起效迅速,疗程缩短,效果显著,安全性高,具有临床推广价值。
Objective: To investigate the clinical efficacy and safety of Fufang Que Decoction syrup for relieving cough and phlegm in children with acute respiratory infection. Methods: Totally 62 children with acute upper respiratory tract infection and cough and expectoration were randomly divided into study group (31 cases) and control group (31 cases). The study group was given Fufang Erzhi syrup, while the control group was treated with Xiaerfefei Kechuan oral liquid. Results: After the treatment, the total effective rates of the control group and the study group were 61.29% and 90.32%, respectively. The total effective rate of the two groups was statistically significant (P <0.05). The cough and expectoration Difficulties and days of hospitalization were significantly less than the control group, the difference was statistically significant (P <0.05). CONCLUSION: Fufangdodecan syrup can treat acute respiratory infection in children with rapid onset of action, short course of treatment, significant effect and high safety, and has clinical value of popularization.